Integration of microRNA changes in vivo identifies novel molecular features of muscle insulin resistance in type 2 diabetes
-
* Corresponding author: James A Timmons Jamie.Timmons@gmail.com
- Equal contributors
1 Translational Biomedicine, Heriot-Watt University, Edinburgh, EH14 4AS, UK
2 Centre for Inflammation and Metabolism, Department of Infectious Diseases and CMRC, Rigshospitalet, University of Copenhagen, DK2100, Denmark
3 The Wenner-Gren Institute, Arrhenius Laboratories, Stockholm University, SE-106 91 Stockholm, Sweden
4 Wellcome Trust Centre for Gene Regulation and Expression, College of Life Sciences, University of Dundee, Dundee, DD1 5EH, UK
5 Department of Biochemistry, Scripps Research Institute, Jupiter, FL33458, USA
6 Royal Veterinary College, University of London, Royal College Street, London, NW1, UK
7 Centre for Healthy Ageing, Department of Biomedical Sciences, Panum Institutet, University of Copenhagen, Blegdamsvej 3B, DK-2200, Denmark
Genome Medicine 2010, 2:9 doi:10.1186/gm130
Published: 1 February 2010Additional files
Additional file 1:
Figures S1 to S6, Tables S1 to S4 and supplementary Results and Discussion.
Format: DOC Size: 2.4MB Download file
This file can be viewed with: Microsoft Word Viewer
Additional file 2:
miRNA lists and subject demographics.
Format: XLS Size: 2.1MB Download file
This file can be viewed with: Microsoft Excel Viewer
